Research of the employee

Bonn - Köln | Hannover - Braunschweig

PANTIPA—Preclinical development of patient-derived monoclonal antibodies targeting Pseudomonas aeruginosa

Pseudomonas aeruginosa is a multidrug-resistant bacterium that can cause life-threatening infections, such as sepsis and pneumonia. One of the key weapons used by this bacterium is the type III secretion system (T3SS), which contains the protein PcrV. Researchers at the DZIF discovered that patients with chronic infections develop highly effective [...]

Read more
Bonn - Köln | Hamburg - Lübeck - Borstel - Riems | Hannover - Braunschweig | Tübingen

PAFAP—Pseudomonas aeruginosa-focused anti-infectives pipeline

In the current WHO list of bacterial priority pathogens (WHO BPPL 2024), the World Health Organisation classifies carbapenem-resistant Pseudomonas aeruginosa bacteria as a high-priority pathogen, which means there is an urgent need for new anti-infectives to combat this problematic bacterium. To address this need, the PAFAP project has brought together a [...]

Read more

Publications of the employee

All publications